Cabozantinib(Cabometyx)

Another NameXL184、LUCICABOZ、Caboxen、Cazanat、卡博替尼

IndicationsIndicated for advanced renal cell carcinoma, hepatocellular carcinoma previously treated with sorafenib, as well as specific metastatic thyroid cancers and neuroendocrine tumors that have progressed a